基于中医传承辅助系统治疗小儿泄泻组方规律分析

目的:基于中医传承辅助系统软件,总结中国期刊全文数据库(CNKI)中中医药治疗小儿泄泻的组方用药规律。方法:收集治疗小儿泄泻的方剂,将方剂信息录入中医传承辅助系统(V2.0.1),利用数据改进互信息法、复杂系统熵聚类、无监督熵层次聚类等数据挖掘方法,分析小儿泄泻方剂的组方规律。结果:对数据库小儿泄泻149条方剂记录进行了分析,得出药物用药频次、常用药对、药物之间的关联规则发现核心药物组合18个,挖掘出新处方共9个。结论:通过中医传承辅助平台可对小儿泄泻方剂数据进行分析,阐明了近年来治疗小儿泄泻的用药规律,其组方以健脾祛湿为主;基于熵层次聚类算法的新方以清热利湿为主,对研究中医药治疗小儿泄泻提供参考依据。     

叶天士治疗虚劳的用药规律挖掘研究

①目的探讨叶天士治疗虚劳的处方用药规律。②方法将《临证指南医案》、《种福堂公选医案》、《普济本事方释义》中治疗虚劳的处方录入中医传承辅助系统,利用软件集成的关联、规则分析、改进的互信息法、复杂系统熵聚类、无监督的熵层次聚类等数据挖掘方法,对叶天士治疗虚劳的处方用药规律进行数据挖掘分析。③结果共筛选出治疗虚劳的处方145首,用药频次排在前5位是茯苓（87）、人参（69）、熟地（45）、五味子（40）、大枣（38）,演化得到核心组合10个、新处方5个。④结论中医传承辅助系统的多角度分析,表明叶天士治疗虚劳重视脾肾,兼顾气血,用药规律是以运用建中焦,固下焦,温补脾肾气血之药为主。     

基于中医传承辅助系统分析叶桂治疗木乘土的用药规律

目的基于中医传承辅助系统,探讨叶桂治疗木乘土的用药规律。方法参考《临证指南医案》(北京科学技术出版社)中收集的治疗木乘土的医案,筛选并运用中医传承辅助系统(V2.0)建立方剂文献研究数据库,采用规则分析、复杂系统熵聚类、无监督的熵层次聚类等数据挖掘方法,对叶桂治疗木乘土的用药规律进行统计和分析。结果筛选治疗木乘土医案55例,12例复诊,共70首方剂,涉及中药92种;方剂中使用频率最高的药物为茯苓,使用频率最高的药物组合为人参-茯苓,占总方剂的41.43%;演化得到核心组合16个,新处方8首。结论叶桂治疗木乘土组方以健脾益气、疏肝理气为主,为临床治疗此类疾病提供参考。     

基于《中医方剂大辞典》中治疗腹痛的组方规律研究

目的采用关联规则apriori算法、复杂系统熵聚类等无监督数据挖掘方法,探索《中医方剂大辞典》中历代腹痛方剂中各种药物的使用及药物之间的关联规律。方法采用《中医传承辅助平台》(V2. 5),提取《中医方剂大词典》中治疗腹痛的有效方剂,构建数据库,使用软件关联规则算法,复杂系统熵聚类等数据挖掘方法,分析治疗腹痛方剂中常用的药物及其组合规律、提取核心组合形成新方。结果纳入《中医方剂大辞典》中治疗腹痛的有效方剂共1331首,共涉及中药721味,出现频率高于90的药物共31味,总结了常用药对36对,通过数据挖掘共得到治疗腹痛的核心用药组合10对,并演化新方组合5首。结论《中医方剂大辞典》收录了从秦汉至现代的中医临床验方,多用理气止痛、和络止痛、健脾助运、散寒温里、缓急止痛之品,中医传承辅助平台系统对于挖掘名老中医临床经验具有重要使用价值。     

基于中医传承辅助系统分析李世增教授治疗痤疮用药经验

目的:基于中医传承辅助系统(V1.1)软件,分析李世增教授治疗痤疮的用药经验。方法:收集李世增教授治疗痤疮的首诊病案152例,录入"中医传承辅助系统",采用该软件集成的规则分析、改进互信息法、复杂系统熵聚类及无监督的熵层次聚类等数据挖掘方法,分析李世增教授治疗痤疮的用药经验。结果:对152首处方进行分析,确定处方中各种药物的使用频次,药物之间的关联规则,演化得到核心组合45个、新处方9个。结论:李世增教授治疗痤疮具有用药组合多样性和用药集中性的特点,符合其对痤疮的五脏论治结合随证(症)加减的证治经验。     

基于中医传承辅助平台王庆国教授治疗类风湿性关节炎用药规律研究

目的:基于中医传承辅助平台系统(V2.5)软件,分析王庆国教授治疗类风湿性关节炎的用药规律。方法:收集王庆国教授治疗类风湿性关节炎的临床病例,首先运用"中医传承辅助平台"系统中的"临床采集"模块进行病例资料的录入,然后运用"数据分析"功能中的规则分析、改进互信息法、复杂系统熵聚类、无监督的熵层次聚类方法等分析王庆国教授治疗类风湿性关节炎的用药规律。结果:对选定的107个处方进行分析,确定处方中药物的使用频次和关联规则,并进一步挖掘出16个核心组合和8首新处方。结论:王庆国教授治疗类风湿性关节炎善于抓住湿热痹阻的核心病机,注重寒温同调,攻补兼施,临床喜用经方,不弃时方,古今接轨,疗效卓著。中医传承辅助系统的数据分析结果与专家临床辨证论治心得基本吻合。因此,本系统适用于名老中医学术经验的整理挖掘与传承发扬。     

基于中医传承辅助平台的中药穴位贴敷治疗冠心病心绞痛用药规律分析

目的:基于中医传承辅助平台2.5软件,探讨中药穴位贴敷治疗冠心病心绞痛的用药规律。方法 :收集中国知网数据库(CNKI)、万方中文期刊数据库、维普中文数据库(VIP)中自1956年至2015年12月所有中药穴位贴敷治疗冠心病心绞痛的方剂,运用中医传承辅助平台构建数据库,使用软件集成改进的互信息法、复杂系统熵聚类、无监督的熵层次聚类等数据挖掘方法,分析穴位贴敷治疗冠心病心绞痛用药规律。结果:筛选出73个穴位贴敷治疗冠心病心绞痛的处方,确定了处方中药物的使用频次规律,药物之间的关联规则,挖掘出12个核心组合和6首新处方。结论:中药穴位贴敷治疗冠心病心绞痛以活血化瘀之品为主,佐以芳香温通、理气化痰药物。     

基于中医传承辅助平台分析《外科发挥》治疗外科疾病的用药规律

目的基于中医传承辅助平台,探讨《外科发挥》中治疗外科疾病内服方剂的用药规律。方法检索并整理《外科发挥》中治疗外科疾病的内服方剂,应用中医传承辅助平台中的关联规则分析、复杂系统熵聚类及无监督熵层次聚类等挖掘方法,对《外科发挥》中治疗外科疾病内服方剂的用药规律进行分析。结果筛选出内服方192首,涉及中药207味;使用频数≥10的有43味,排在前4位的分别是生甘草、当归、人参、茯苓;频数≥30次的药物组合共12个,使用频数最高的药物组合为人参-生甘草、生甘草-当归;演化出3~4味药的核心组合Ⅰ和Ⅱ为23对,在以上核心组合提取的基础上,进一步聚类得到新处方23个。结论薛己临证辨治外科疾病注重活血化瘀、托补内消、养阴生肌,为临床辨治中医外科疾病用药提供科学的理论指导。     

基于数据挖掘探讨腹泻型肠易激综合征组方用药规律

目的:应用中医传承辅助平台(V2.5)软件分析治疗腹泻型肠易激综合征(IBS-D)内服方剂的组方用药规律,以期为临床遣方用药和开发新型中成药提供参考.方法:搜集中文期刊文献中口服中药汤剂治疗IBS-D的处方,采用中医传承辅助平台的数据挖掘方法,通过软件集成的关联规则和复杂系统熵聚类等方法分析组方用药规律.结果:纳入处方...     

基于数据挖掘技术探讨徐志瑛教授辨治肝硬化腹水的用药规律

探讨名老中医徐志瑛教授治疗肝硬化腹水的用药规律.[方法]收集徐志瑛教授治疗肝硬化腹水患者的处方,将所得资料导入中医传承辅助平台,采用复杂系统熵聚类等无监督数据挖掘方法,对其处方用药经验进行总结.[结果]对筛选出的138首处方进行分析,确定处方中药物的使用频次,药物之间的关联规则,挖掘出8个核心组合和4首新处方.[结论]...     

APPLICATION OF LORNOXICAM TO PATIENT-CONTROLLED ANALGESIA IN PATIENTS UNDERGOING ABDOMINAL SURGERIES

FOR anesthesiologis s ,treatingpostoperativepainhas alwaysbeen a problem.Althoughopioidshave been provedtobe effective,theirsideeffectscouldnotbeignored.With thedevelopmentofscienceand pharmacology,many drugs with aspectsof satisfactoryanalgesicefficacyand couldbe welltoleratedby patientshave been developed.And lornoxicamisone of them, which isa non-steroidalanti-inflammatorydrug (NSAID ), with analgesic, anti-infl-ammatory,andantipyreticproperties.Itseliminationhalf-time(3 to 5 hours) isle…     

Dr.Zhang Ren''''s Experience in the Acupuncture Treatment of Different Diseases with the Same Therapeutic Principle

Dr.Zhang Ren,the chief physician,is the chairman of Shanghai Acupuncture and Moxibustion Association.Having been engaged in medicine for about 40 years,he is experienced in treating various intractable diseases.In his long years of clinical practice,he advocates taking the TCM differentiation as the basis to seek for the acupuncture method for treatment of modern intractable diseases.The author of this essay had the fortune to follow Dr.Zhang in study.The following is a summary of Dr.Zhang's experience in the acupuncture treatment for different intractable diseases with the same therapeutic principle.     

Luo Lingjie''''s Experience in Treating Chronic Nephropathy

In treating chronic nephropathy,Luo Lingjie,a chief physician,pays attention to regulating the balance between yin and yang,treating infection if present,and removing pathogenic factors.He prescribes gentle drugs and uses carefully strongly warming-tonifying ones,emphasizes the importance of persuading the patient to persist in treatment with medication and nurse one's health for recuperation,and is good at combined use of TCM and western medicine therapy and brings the merits of various therapies into full play,with obvious theraoeutic effects.     

Acupuncture Combined with Spinal Tui Na for Treatment of Primary Dysmenorrhea in 30 Cases

Objective: To observe the therapeutic effects in acupunture treatment of primary dysmenorrhea combined with spinal Tui Na, and study its mechanism. Methods: Thirty cases of the treatment group were treated by acupuncture combined with spinal Tui Na, and thirty cases in the control group were treated by routine acupuncture. Results: The total effective rate was 93.3% in the treatment group, and 73.3% in the control group, with a significant difference between the two groups (P<0.05). Conclusions: Acupuncture combined with spinal Tui Na has good prospects for treatment of primary dysmenorrhea.     

猪肺磷脂注射液联合经鼻持续气道正压通气对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性的影响

目的 探讨猪肺磷脂注射液联合经鼻持续气道正压通气(NCPAP)对呼吸衰竭早产儿的临床疗效及肌酸激酶同工酶活性(CK-MB)的影响.方法 选取呼吸衰竭早产儿80例,分为观察组和对照组各40例.对照组采用NCPAP给氧治疗,观察组给予NCPAP给氧联合猪肺磷脂气管内给药.观察两组患儿治疗前及治疗12h、24 h后PaO2、PaCO2、血氧饱和度(SaO2)、pH的变化情况,检测治疗前及治疗5d后血清CK-MB水平;评估两组患儿的临床治疗效果.结果 两组患儿PaO2、PaCO2、SaO2、pH比较,差异均有统计学意义(P＜0.05),其中观察组治疗后的PaO2、SaO2、pH均高于对照组,PaCO2则低于对照组.两组的PaO2、SaO2、pH均随观察时间延长而升高(P＜0.05),PaCO2均随观察时间的延长而降低(P＜0.05).观察组治疗有效率为87.5％,显著高于对照组的70.0％ (P ＜0.05).治疗5d后两组患儿血清CK-MB水平均较前降低(P＜0.05),且观察组明显低于对照组(P＜0.05).结论 猪肺磷脂注射液气管内给药联合NCPAP可以显著降低呼吸衰竭早产儿CK-MB的含量,提高治疗有效率,起到很好的呼吸循环支持作用.     

Survey and practice of reporting quality of randomized controlled clinical trials on traditional Chinese medicine

Evidence obtained from randomized controlled trials （RCTs） has been generally accepted as the gold standard in the evaluation of clinical effectiveness. Readers need to understand the trial design, implementation, results, analysis and interpretation, so as to fully Jnderstand the results of RCTs. Thus, the investigators of RCTs have to report these items in a complete, accurate and clear manner. Since 1998, we have conducted several evaluations on the reporting quality of RCTs published in Chinese journals on traditional Chinese medicine （TCM） and results have shown that there is an urgent need for higher quality RCTs on TCM.     

TCM Treatment of Ankylosing Spondylitis by Tonifying the Kidney and Strengthening the Governor Vessel

Ankylosing spondylitis is a chronic and progressive disorder with inflammation mainly involving the central axis joints. It mainly affects the cervical spine and the lumbosacral area, with the pathogenesis closely related to the kidney and the Governor Vessel (GV). TCM holds that the syndrome is deficiency in origin and excess in superficiality, which is due to insufficiency of the kidney, deficiency of GV, and blocking of the channels with the invasion of exogenous evil, leading to poor circulation of qi and blood and malnutrition of the bones, muscles and joints. The TCM method of tonifying the kidney and strengthening GV to regulate circulation of qi and blood and check the arthralgia pain should be adopted, with the Kidney-Tonifying and GV Strengthening Decoction (益肾强督汤) prescribed.     

IMPROVING P-gp EXPRESSION IN HUMAN MONONUCLEAR CELLS IN VITRO TRANSFECTED BY MULTIDRUG RESISTANCE-1 mRNA

CHEMOTHERAPY playsa greatrolein the treat- ment of malignanttumors,especiallyingynecolo- gicalones.But inanticancerchemotherapy,leuko-cytopeniaisfrequentlytheprimarydose-limitingsideeffect factor.Moreover,cancersarefrequentlychemoresistantbe-causeof overexpressionof P-glycoprotein(P-gp), which isencodedby multidrugresistancegene (MDR1 ) and detectableinup to50% ofhuman cancersand renderscellsresistancetoanticancerdrugs.The safetyand potentialtherapeuticbenefitof mdr1 gene transferredto h…